People with melanoma, ovarian cancer, or prostate cancer now have a new resource that provides them with the same credible information their physicians use when determining treatment options. The National Comprehensive Cancer Network (NCCN?) earlier today announced the addition of three new NCCN Guidelines for Patients? to the library of patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines?).
The new guidelines for patients discuss melanoma, ovarian cancer, and prostate cancer and are designed to provide people with cancer and their caregivers with state-of-the-art treatment information in easy-to-understand language.
Given the prevalence of melanoma and prostate cancer ? both among the most frequently diagnosed cancers in men ? and the challenges in detecting ovarian cancer in women, it is critical that patients have resources to empower them to take a more active role in their treatment.
In developing these guidelines, a multidisciplinary panels of experts from NCCN Member Institutions were involved. The guidlines feature algorithms or ?decision trees? that address every appropriate treatment option from initial work up throughout the course of the disease. The guidelines for patients translate these professional guidelines in a clear, step-by-step manner that patients can use as the basis for making decisions and discussing options with their physicians.
For more information:
National Comprehensive Cancer Network (NCCN)
